NOVEL BIOMARKER FOR CANCER IMMUNOTHERAPY Application EP-3597766-A4 European Patent Office 25 Nov 2020
USE OF IMMUNE DIVERSITY AS A PREDICTIVE MARKER FOR IDENTIFYING PATIENTS LIKELY TO RESPOND… Application WO-2015162596-A1 World Intellectual Property Organisation (WIPO) 29 Oct 2015